[go: up one dir, main page]

FR2736267B1 - Conservateur pour composition vaccinale - Google Patents

Conservateur pour composition vaccinale

Info

Publication number
FR2736267B1
FR2736267B1 FR9508323A FR9508323A FR2736267B1 FR 2736267 B1 FR2736267 B1 FR 2736267B1 FR 9508323 A FR9508323 A FR 9508323A FR 9508323 A FR9508323 A FR 9508323A FR 2736267 B1 FR2736267 B1 FR 2736267B1
Authority
FR
France
Prior art keywords
preservative
vaccine composition
vaccine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9508323A
Other languages
English (en)
Other versions
FR2736267A1 (fr
Inventor
Pierre Heimendinger
Alain Francon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Pasteur Merieux Serum et Vaccines SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serum et Vaccines SA filed Critical Pasteur Merieux Serum et Vaccines SA
Priority to FR9508323A priority Critical patent/FR2736267B1/fr
Priority to AU65219/96A priority patent/AU6521996A/en
Priority to PCT/FR1996/001042 priority patent/WO1997002044A1/fr
Publication of FR2736267A1 publication Critical patent/FR2736267A1/fr
Application granted granted Critical
Publication of FR2736267B1 publication Critical patent/FR2736267B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9508323A 1995-07-05 1995-07-05 Conservateur pour composition vaccinale Expired - Fee Related FR2736267B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9508323A FR2736267B1 (fr) 1995-07-05 1995-07-05 Conservateur pour composition vaccinale
AU65219/96A AU6521996A (en) 1995-07-05 1996-07-04 Preservative for a vaccine composition
PCT/FR1996/001042 WO1997002044A1 (fr) 1995-07-05 1996-07-04 Conservateur pour composition vaccinale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9508323A FR2736267B1 (fr) 1995-07-05 1995-07-05 Conservateur pour composition vaccinale

Publications (2)

Publication Number Publication Date
FR2736267A1 FR2736267A1 (fr) 1997-01-10
FR2736267B1 true FR2736267B1 (fr) 1997-08-08

Family

ID=9480849

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9508323A Expired - Fee Related FR2736267B1 (fr) 1995-07-05 1995-07-05 Conservateur pour composition vaccinale

Country Status (3)

Country Link
AU (1) AU6521996A (fr)
FR (1) FR2736267B1 (fr)
WO (1) WO1997002044A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110188A (en) * 1998-03-09 2000-08-29 Corvascular, Inc. Anastomosis method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391373A (en) * 1992-07-01 1995-02-21 Chanel, Inc. Skin cream composition

Also Published As

Publication number Publication date
AU6521996A (en) 1997-02-05
FR2736267A1 (fr) 1997-01-10
WO1997002044A1 (fr) 1997-01-23

Similar Documents

Publication Publication Date Title
EP0764083A4 (fr) Composition pour film
DE69531318D1 (de) Shampoozusammensetzung
NO962606D0 (no) Farmasöytisk sammensetning
FI973518L (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
FI972945L (fi) Antigeenien antamiseen soveltuvia koostumuksia
FI954773A (fi) Antihypertriglyserideeminen koostumus
BR9607058A (pt) Composição
BR9606809A (pt) Composição inseticidamente ativa
ID17860A (id) Komposisi vaksin
DE69725603D1 (de) Verbesserte verpackungszusammensetzung
NO973575D0 (no) Ny konserveringsmiddelsammensetning
DE69628629D1 (de) Emulsionszusammensetzung
PT728814E (pt) Composicao betuminosa
BR9609903A (pt) ComposiçÃo inseticidamente ativa
DE69607338D1 (de) Entschäumungszusammensetzung
BR9507768A (pt) Composição farmacêutica
DE69601899D1 (de) Zementzusammensetzung
LV11727A (lv) Farmaceitiska kompozicija
DE69616374D1 (de) Germizide zusammensetzung
BR9609790A (pt) Composição espumante embalada
ID18698A (id) Komposisi farmasi
FI973280A0 (fi) Farmaseuttinen koostumus
BR9605972A (pt) Composição de xampu
BR9607946A (pt) Composição
ATE183114T1 (de) Feste zusammensetzung

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
CD Change of name or company name
ST Notification of lapse

Effective date: 20090331